These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 29528590)

  • 21. Association of the gene polymorphisms in sodium taurocholate cotransporting polypeptide with the outcomes of hepatitis B infection in Chinese Han population.
    Su Z; Li Y; Liao Y; Cai B; Chen J; Zhang J; Li L; Ying B; Tao C; Wang L
    Infect Genet Evol; 2014 Oct; 27():77-82. PubMed ID: 25010264
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Toll-like receptor 9 polymorphisms and Hepatitis B virus clearance in Moroccan chronic carriers.
    Chihab H; Zaidane I; Elhabazi A; Jadid FZ; El Fihri R; Elmessaoudi-Idrissi M; Chair M; Badre W; Tahiri M; Pineau P; Chemin I; Ezzikouri S; Benjelloun S
    Gene; 2019 Mar; 687():212-218. PubMed ID: 30453064
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of Inducible T Cell Costimulator Polymorphisms with Susceptibility and Outcome of Hepatitis B Virus Infection in a Chinese Han Population.
    Hu J; Li QL; Hou SH; Peng H; Guo JJ
    Scand J Immunol; 2015 Sep; 82(3):275-81. PubMed ID: 26074057
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human genetic susceptibility to hepatitis B virus infection.
    Xu J; Zhan Q; Fan Y; Yu Y; Zeng Z
    Infect Genet Evol; 2021 Jan; 87():104663. PubMed ID: 33278635
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical Relevance of HLA Gene Variants in HBV Infection.
    Wang L; Zou ZQ; Wang K
    J Immunol Res; 2016; 2016():9069375. PubMed ID: 27243039
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of polymorphism in MicroRNA 219-1 with clearance of hepatitis B virus infection.
    Cheong JY; Shin HD; Kim YJ; Cho SW
    J Med Virol; 2013 May; 85(5):808-14. PubMed ID: 23508906
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fine mapping analysis of HLA-DP/DQ gene clusters on chromosome 6 reveals multiple susceptibility loci for HBV infection.
    Tao J; Su K; Yu C; Liu X; Wu W; Xu W; Jiang B; Luo R; Yao J; Zhou J; Zhan Y; Ye C; Yuan W; Jiang X; Cui W; Li MD; Li L
    Amino Acids; 2015 Dec; 47(12):2623-34. PubMed ID: 26197724
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Polymorphism of TLR5 rs5744174 is associated with disease progression in Chinese patients with chronic HBV infection.
    Cao L; Zhang T; Zhu J; Li A; Zheng K; Zhang N; Su B; Xia W; Wu H; Li N; He Q
    APMIS; 2017 Aug; 125(8):708-716. PubMed ID: 28543911
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impacts of human leukocyte antigen DQ genetic polymorphisms and their interactions with hepatitis B virus mutations on the risks of viral persistence, liver cirrhosis, and hepatocellular carcinoma.
    Ji X; Zhang Q; Li B; Du Y; Yin J; Liu W; Zhang H; Cao G
    Infect Genet Evol; 2014 Dec; 28():201-9. PubMed ID: 25281206
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Influence of B and T Lymphocyte Attenuator Genetic Variants on Susceptibility to Chronic Hepatitis B Virus Infection.
    Tang J; Fei J; Gu C; Liu W; Li M; Zhou C
    Cell Physiol Biochem; 2018; 45(6):2540-2547. PubMed ID: 29558758
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Toll-like receptor (TLR)-mediated innate immune responses in the control of hepatitis B virus (HBV) infection.
    Zhang E; Lu M
    Med Microbiol Immunol; 2015 Feb; 204(1):11-20. PubMed ID: 25550115
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The interferon receptor-1 promoter polymorphisms affect the outcome of Caucasians with HBeAg-negative chronic HBV infection.
    Karamitros T; Papatheodoridis G; Dimopoulou E; Papageorgiou MV; Paraskevis D; Magiorkinis G; Sypsa V; Hatzakis A
    Liver Int; 2015 Dec; 35(12):2506-13. PubMed ID: 25939635
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intrahepatic innate immune response pathways are downregulated in untreated chronic hepatitis B.
    Lebossé F; Testoni B; Fresquet J; Facchetti F; Galmozzi E; Fournier M; Hervieu V; Berthillon P; Berby F; Bordes I; Durantel D; Levrero M; Lampertico P; Zoulim F
    J Hepatol; 2017 May; 66(5):897-909. PubMed ID: 28043874
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Toll-like receptor-mediated control of HBV replication by nonparenchymal liver cells in mice.
    Wu J; Lu M; Meng Z; Trippler M; Broering R; Szczeponek A; Krux F; Dittmer U; Roggendorf M; Gerken G; Schlaak JF
    Hepatology; 2007 Dec; 46(6):1769-78. PubMed ID: 17929296
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Toll-Like Receptor 3 is Associated With the Risk of HCV Infection and HBV-Related Diseases.
    Geng PL; Song LX; An H; Huang JY; Li S; Zeng XT
    Medicine (Baltimore); 2016 May; 95(21):e2302. PubMed ID: 27227908
    [TBL] [Abstract][Full Text] [Related]  

  • 36. RANTES, MCP-1, CCR2, CCR5, CXCR1 and CXCR4 gene polymorphisms are not associated with the outcome of hepatitis B virus infection: results from a large scale single ethnic population.
    Cheong JY; Cho SW; Choi JY; Lee JA; Kim MH; Lee JE; Hahm KB; Kim JH
    J Korean Med Sci; 2007 Jun; 22(3):529-35. PubMed ID: 17596666
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interleukin-18 promoter polymorphisms and the disease progression of Hepatitis B virus-related liver disease.
    Migita K; Sawakami-Kobayashi K; Maeda Y; Nakao K; Kondoh S; Sugiura M; Kawasumi R; Segawa O; Tajima H; Machida M; Nakamura M; Yano K; Abiru S; Kawasaki E; Yatsuhashi H; Eguchi K; Ishibashi H
    Transl Res; 2009 Feb; 153(2):91-6. PubMed ID: 19138654
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interferon-β response is impaired by hepatitis B virus infection in Tupaia belangeri.
    Kayesh MEH; Ezzikouri S; Chi H; Sanada T; Yamamoto N; Kitab B; Haraguchi T; Matsuyama R; Nkogue CN; Hatai H; Miyoshi N; Murakami S; Tanaka Y; Takano JI; Shiogama Y; Yasutomi Y; Kohara M; Tsukiyama-Kohara K
    Virus Res; 2017 Jun; 237():47-57. PubMed ID: 28551415
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatitis B virus genome replication triggers toll-like receptor 3-dependent interferon responses in the absence of hepatitis B surface antigen.
    Real CI; Lu M; Liu J; Huang X; Trippler M; Hossbach M; Deckert J; Jahn-Hofmann K; Ickenstein LM; John MJ; Gibbert K; Dittmer U; Vornlocher HP; Schirmbeck R; Gerken G; Schlaak JF; Broering R
    Sci Rep; 2016 Apr; 6():24865. PubMed ID: 27121087
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Toll-like receptor 3 gene polymorphisms and severity of pandemic A/H1N1/2009 influenza in otherwise healthy children.
    Esposito S; Molteni CG; Giliani S; Mazza C; Scala A; Tagliaferri L; Pelucchi C; Fossali E; Plebani A; Principi N
    Virol J; 2012 Nov; 9():270. PubMed ID: 23151015
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.